Skip to main content
Premium Trial:

Request an Annual Quote

Ardais Expands Aventis Collaboration

NEW YORK, April 6 (GenomeWeb News) - Ardais today said that it has extended a research collaboration with Aventis that the companies began in 2002.

Under the terms of the original collaboration, Aventis was granted access to Ardais' BIGR (Biomaterials and Information for Genomic Research) library of clinical data and biomaterials. Under the expanded agreement, Ardais will use this platform in combination with immunohistochemistry profiling "to assess the potential of certain biological targets in the pharmaceutical company's R&D pipeline."

Ardais said it would use its technology to optimize validation assays and assist in the characterization of targets in panels of normal and diseased human tissues.

Financial terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more